RECURRENT EPENDYMOMA

Clinical trials for RECURRENT EPENDYMOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT EPENDYMOMA trials appear

Sign up with your email to follow new studies for RECURRENT EPENDYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 8 Completed 2

New hope for kids with deadly brain cancer? drug ONC206 enters human trials

Disease control Recruiting now

This early-phase trial tests a new drug called ONC206 in children and young adults with diffuse midline glioma or other recurrent brain tumors. The drug aims to kill cancer cells by causing stress in them, without harming healthy cells. Researchers are looking for the safest dose…

Matched conditions: RECURRENT EPENDYMOMA

Phase: PHASE1 • Sponsor: Sabine Mueller, MD, PhD • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

RECURRENT EPENDYMOMA

Get alerted when new RECURRENT EPENDYMOMA trials appear

New hope for kids with deadly brain cancer? drug ONC206 enters human trials